Cargando…

Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis

BACKGROUND: Psoriasis localized to certain body areas, such as the scalp, nails, palms, soles, intertriginous regions, and genital regions, is reportedly difficult to treat. OBJECTIVE: To investigate the biologics-resistant areas in South Korean patients with psoriasis treated with biologics. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Sang-Hyeon, Shin, Bong Seok, Bae, Kyung-Nam, Son, Jin-Hwa, Shin, Kihyuk, Kim, Hoon-Soo, Ko, Hyun-Chang, Kim, Moon-Bum, Kim, Byung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905854/
https://www.ncbi.nlm.nih.gov/pubmed/36750453
http://dx.doi.org/10.5021/ad.21.274
_version_ 1784883891044089856
author Won, Sang-Hyeon
Shin, Bong Seok
Bae, Kyung-Nam
Son, Jin-Hwa
Shin, Kihyuk
Kim, Hoon-Soo
Ko, Hyun-Chang
Kim, Moon-Bum
Kim, Byung-Soo
author_facet Won, Sang-Hyeon
Shin, Bong Seok
Bae, Kyung-Nam
Son, Jin-Hwa
Shin, Kihyuk
Kim, Hoon-Soo
Ko, Hyun-Chang
Kim, Moon-Bum
Kim, Byung-Soo
author_sort Won, Sang-Hyeon
collection PubMed
description BACKGROUND: Psoriasis localized to certain body areas, such as the scalp, nails, palms, soles, intertriginous regions, and genital regions, is reportedly difficult to treat. OBJECTIVE: To investigate the biologics-resistant areas in South Korean patients with psoriasis treated with biologics. METHODS: The study included 50 patients with chronic moderate to severe plaque psoriasis from the Pusan National University Hospital and Chosun University Hospital between October 2019 and September 2020. The patients had at least one psoriatic lesion, were treated with biologics for more than six months, and exhibited a partial or good response (reaching a Psoriasis Area and Severity Index [PASI] score of 1~5 after biologics treatment). RESULTS: A total of 50 patients with psoriasis (32 male, mean±standard deviation 47.8±11 years), with a median PASI score of 1.8, were included. The most common biologics-resistant areas were the anterior lower leg (56.0%), followed by the knee (48.0%) and posterior lower leg (42.0%). The proportion of biologics-resistant areas were obtained for body regions traditionally considered as difficult-to-treat entities, including the fingernails (10.0%), toenails (14.0%), scalp (38.0%), palm (12.0%), sole (14.0%), and genital areas (10.0%). CONCLUSION: This study determined the biologics-resistant areas in South Korean patients, successfully treated with biologics, in a real-world clinical setting.
format Online
Article
Text
id pubmed-9905854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-99058542023-02-16 Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis Won, Sang-Hyeon Shin, Bong Seok Bae, Kyung-Nam Son, Jin-Hwa Shin, Kihyuk Kim, Hoon-Soo Ko, Hyun-Chang Kim, Moon-Bum Kim, Byung-Soo Ann Dermatol Original Article BACKGROUND: Psoriasis localized to certain body areas, such as the scalp, nails, palms, soles, intertriginous regions, and genital regions, is reportedly difficult to treat. OBJECTIVE: To investigate the biologics-resistant areas in South Korean patients with psoriasis treated with biologics. METHODS: The study included 50 patients with chronic moderate to severe plaque psoriasis from the Pusan National University Hospital and Chosun University Hospital between October 2019 and September 2020. The patients had at least one psoriatic lesion, were treated with biologics for more than six months, and exhibited a partial or good response (reaching a Psoriasis Area and Severity Index [PASI] score of 1~5 after biologics treatment). RESULTS: A total of 50 patients with psoriasis (32 male, mean±standard deviation 47.8±11 years), with a median PASI score of 1.8, were included. The most common biologics-resistant areas were the anterior lower leg (56.0%), followed by the knee (48.0%) and posterior lower leg (42.0%). The proportion of biologics-resistant areas were obtained for body regions traditionally considered as difficult-to-treat entities, including the fingernails (10.0%), toenails (14.0%), scalp (38.0%), palm (12.0%), sole (14.0%), and genital areas (10.0%). CONCLUSION: This study determined the biologics-resistant areas in South Korean patients, successfully treated with biologics, in a real-world clinical setting. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023-02 2023-01-20 /pmc/articles/PMC9905854/ /pubmed/36750453 http://dx.doi.org/10.5021/ad.21.274 Text en Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Won, Sang-Hyeon
Shin, Bong Seok
Bae, Kyung-Nam
Son, Jin-Hwa
Shin, Kihyuk
Kim, Hoon-Soo
Ko, Hyun-Chang
Kim, Moon-Bum
Kim, Byung-Soo
Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title_full Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title_fullStr Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title_full_unstemmed Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title_short Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
title_sort which areas are still left in biologics responsive korean patients with moderate to severe plaque psoriasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905854/
https://www.ncbi.nlm.nih.gov/pubmed/36750453
http://dx.doi.org/10.5021/ad.21.274
work_keys_str_mv AT wonsanghyeon whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT shinbongseok whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT baekyungnam whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT sonjinhwa whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT shinkihyuk whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT kimhoonsoo whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT kohyunchang whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT kimmoonbum whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis
AT kimbyungsoo whichareasarestillleftinbiologicsresponsivekoreanpatientswithmoderatetosevereplaquepsoriasis